Skandinaviska Enskilda Banken AB publ Has $16.19 Million Holdings in Zoetis Inc. (ZTS)
Skandinaviska Enskilda Banken AB publ lifted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 2.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 253,926 shares of the company’s stock after purchasing an additional 5,700 shares during the period. Skandinaviska Enskilda Banken AB publ owned 0.05% of Zoetis worth $16,190,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in ZTS. BlackRock Inc. boosted its holdings in Zoetis by 3.9% in the second quarter. BlackRock Inc. now owns 37,495,299 shares of the company’s stock valued at $2,338,957,000 after acquiring an additional 1,412,829 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Zoetis by 2.8% in the second quarter. Vanguard Group Inc. now owns 33,654,686 shares of the company’s stock valued at $2,099,379,000 after acquiring an additional 910,265 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Zoetis by 55.4% in the second quarter. Alliancebernstein L.P. now owns 10,370,388 shares of the company’s stock valued at $646,905,000 after acquiring an additional 3,695,449 shares during the last quarter. American Century Companies Inc. boosted its holdings in Zoetis by 7.2% in the second quarter. American Century Companies Inc. now owns 6,207,974 shares of the company’s stock valued at $387,253,000 after acquiring an additional 417,455 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in Zoetis by 7,717.4% in the second quarter. Janus Henderson Group PLC now owns 5,809,086 shares of the company’s stock valued at $362,372,000 after acquiring an additional 5,734,776 shares during the last quarter. Institutional investors own 93.33% of the company’s stock.
Several equities analysts have weighed in on the company. Goldman Sachs Group reissued a “neutral” rating and issued a $62.00 target price on shares of Zoetis in a research note on Monday, August 7th. UBS reissued a “neutral” rating on shares of Zoetis in a research note on Friday, November 24th. BidaskClub lowered Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 20th. Morgan Stanley increased their target price on Zoetis from $61.00 to $70.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $75.00 target price on shares of Zoetis in a research note on Tuesday, October 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have assigned a buy rating to the stock. Zoetis currently has a consensus rating of “Buy” and a consensus price target of $68.24.
Zoetis Inc. (NYSE ZTS) traded up $0.01 during midday trading on Friday, hitting $72.30. The stock had a trading volume of 1,932,240 shares, compared to its average volume of 2,776,670. The firm has a market capitalization of $35,230.00, a price-to-earnings ratio of 32.75, a P/E/G ratio of 2.10 and a beta of 1.02. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. Zoetis Inc. has a 52 week low of $48.55 and a 52 week high of $72.71.
Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.02. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.32 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. Zoetis’s revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.52 earnings per share. analysts anticipate that Zoetis Inc. will post 2.37 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.58%. The ex-dividend date is Wednesday, November 8th. Zoetis’s dividend payout ratio is currently 22.11%.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.